Trials / Completed
CompletedNCT02368080
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults
Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults: a Comparison of Two Commercially Available Devices
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study compares the lung clearance index (LCI) in cystic fibrosis and healthy adults obtained with two different multiple breath nitrogen washout (MBWN2) devices. Each participants will perform the test (LCI) in duplicate on each device.
Detailed description
Using nitrogen as the inert gas, there are currently two commercially available devices that offer the possibility to measure the LCI. However, comparison between them are lacking. The 2 MBWN2 devices are the "EasyOne Pro Lab" (ndd Medical Technologies, Zürich, Switzerland) and the "Exhalyzer D" (Eco Medics AG, Duernten, Switzerland).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Comparison of two MBWN2 devices : "EasyOne Pro Lab" versus "Exhalyzer D" | Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device. |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-12-01
- Completion
- 2014-01-01
- First posted
- 2015-02-20
- Last updated
- 2015-07-30
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02368080. Inclusion in this directory is not an endorsement.